Fougera Pharmaceuticals, LLC FDA Inspection Record

FEI 2432435 · Inspections, Form 483s, warning letters and import refusals

Fougera Pharmaceuticals, LLC is an FDA-registered facility (FEI 2432435) located in Melville, NY, US. Registered operations: ANALYSIS. RegDataLab tracks 12 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Dec 8, 2023: No Action Indicated (NAI)
Inspections on record
12 (11 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
27, latest Mar 2, 2017
Import refusals
8

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 12 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 8, 2023No Action Indicated (NAI)No citations listed
Aug 10, 2022Voluntary Action Indicated (VAI)Reactive/Additive/Absorptive Containers/Closures (21 CFR 211.94(a))
Microbiological testing (21 CFR 211.165(b))
Scientifically sound laboratory controls (21 CFR 211.160(b))
Aug 8, 2019Voluntary Action Indicated (VAI)Written procedures not established/followed (21 CFR 211.67(b))
May 29, 2018Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Nov 10, 2016Voluntary Action Indicated (VAI)No citations listed
Dec 23, 2014Voluntary Action Indicated (VAI)SOPs not followed / documented (21 CFR 211.100(b))
Oct 31, 2013Voluntary Action Indicated (VAI)Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Written in-process control procedures (21 CFR 211.110(a))
Nov 16, 2012Voluntary Action Indicated (VAI)Scientifically sound laboratory controls (21 CFR 211.160(b))
Jun 15, 2012Voluntary Action Indicated (VAI)No citations listed
Feb 9, 2011Voluntary Action Indicated (VAI)No citations listed

Recalls

Showing the 10 most recent of 27 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 2, 2017Class IID-0612-2017Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of…
Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream
Aug 28, 2014Class IID-0245-2015FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a)…
Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as…
Jul 3, 2014Class IIID-1440-2014Triamcinolone Acetonide Lotion USP, 0.1%, 60 mL Bottle, Rx Only, For Dermatologic Use… and 1 more product
Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry.
Jan 29, 2014Class IIID-1152-2014Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera &…
Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.
Nov 18, 2013Class IIID-1044-2014KETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera…
Failed Impurities/Degradation Specifications: Out-of-Specification degradant results.
Jul 18, 2012Class IIID-241-2013Fougera Ketoconazole Cream 2%, 15g tube, Rx only, Labeled with E. Fougera & Co., a…
Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of…
Aug 1, 2011Class IIID-860-2011Ciclopirox Shampoo, 1%, For Topical Use only, 120 mL bottle, Rx only, E. FOUGERA & CO., A…
CGMP Deviations: Out-of-specification (OOS) low viscosity results were obtained during routine stability testing (CRT) for Ciclopirox…
Jul 7, 2011Class IIID-914-2011DESOXIMETASONE CREAM USP 0.25%, a) 15 grams per tube, NDC 0168-0180-15, b) 60 grams per…
Impurities/Degradation Products: Out of Specification (OOS) results, for a degradantion product were obtained during routine stability…
May 3, 2011Class IIID-916-2011DESONIDE OINTMENT, 0.05%,15 grams per tube, Rx only, E. FOUGERA & CO., A division of…
Container Leakage: Out-of-specification results for weight loss.
Mar 30, 2011Class IIID-990-2011DIFLORASONE DIACETATE OINTMENT USP, 0.05%, NET WT 30 grams, Rx only, a) fougera label, NDC…
Product lacks stability: Out-of-specification (OOS) result for low viscosity obtained during stability testing.

FDA record score

8 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

15 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIAug 10, 20226 x 0.63.6
Inspection classified VAIAug 8, 20196 x 0.251.5
Inspection classified VAIMay 29, 20186 x 0.251.5
Class II recall D-0612-2017, this FEI as the recalling firmMar 2, 20174 x 0.251
Inspection classified VAINov 10, 201610 years or older, so it adds no points0
Inspection classified VAIDec 23, 201410 years or older, so it adds no points0
Class II recall D-0245-2015, this FEI as the recalling firmAug 28, 201410 years or older, so it adds no points0
Inspection classified VAIOct 31, 201310 years or older, so it adds no points0
Inspection classified VAINov 16, 201210 years or older, so it adds no points0
Inspection classified VAIJun 15, 201210 years or older, so it adds no points0
Inspection classified VAIFeb 9, 201110 years or older, so it adds no points0
Class II recall D-515-2010, this FEI as the recalling firmMar 30, 201010 years or older, so it adds no points0
Class II recall D-504-2010, this FEI as the recalling firmMar 19, 201010 years or older, so it adds no points0
Inspection classified VAIJan 12, 201010 years or older, so it adds no points0
Inspection classified VAIFeb 6, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Fougera Pharmaceuticals, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Fougera Pharmaceuticals, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Fougera Pharmaceuticals LLC
Location
Melville, NY (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.